Seaweed and human health

Nutrition Reviews

Volumn 72, Issue 3, 2014, Pages 205-216

  Brown, Emma M ^a   Allsopp, Philip J ^a   Magee, Pamela J ^a   Gill, Chris I ^a   Nitecki, Sonja ^a   Strain, Conall R ^a   Mcsorley, Emeir M ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Bioactive; Diet; Disease; Health; Seaweed

Indexed keywords

ALGAL EXTRACT; ALGINIC ACID; AMINO ACID; ASTAXANTHIN; CALCIUM; CARRAGEENAN; CHLOROPHYLL; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FUCOXANTHIN; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; KAHALALIDE F; LAMINARAN; LECTIN; OMEGA 3 FATTY ACID; PEPTIDE; PHYCOBILIPROTEIN; POLYPHENOL; POLYSACCHARIDE; POLYSACCHARIDE SULFATE;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASCOPHYLLUM; BODY MASS; BONE DENSITY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHONDRUS; CHRONIC DISEASE; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM; DISEASE MARKER; FOOD INTAKE; FUCUS; GLUCOSE BLOOD LEVEL; HEALTH; HUMAN; HUMAN HEALTH; INSULIN BLOOD LEVEL; INTESTINE; LAMINARIA; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOPOROSIS; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEAWEED; SPIRULINA PLATENSIS; UNDARIA PINNATIFIDA; WEIGHT REDUCTION; ANIMAL; CHEMISTRY; FUNCTIONAL FOOD; HEALTH FOOD; NUTRITIONAL VALUE;

ANIMALIA;

ANIMALS; FUNCTIONAL FOOD; HEALTH FOOD; HUMANS; NUTRITIVE VALUE; POLYPHENOLS; POLYSACCHARIDES; SEAWEED;

EID: 84895548085     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12091     Document Type: Article

References (146)

1. Iso H. Lifestyle and cardiovascular disease in Japan. J Atheroscler Thromb. 2011;18:83-88.
2. Kim J, Shin A, Lee JS, etal. Dietary factors and breast cancer in Korea: an ecological study. Breast J. 2009;15:683-686.
3. Matsumura Y. Nutrition trends in Japan. Asia Pac J Clin Nutr. 2001;10 (Suppl 1):S40-S47.
4. Jensen A. Present and future needs for algae and algal products. Hydrobiologia. 1993;260-261(1):15-23.
5. Smit AJ. Medicinal and pharmaceutical uses of seaweed natural products: a review. J Appl Phycol. 2004;16:245-262.
6. Cavalli-Sforza LT, Rosman A, de Boer AS, etal. Nutritional aspects of changes in disease patterns in the Western Pacific region. Bull World Health Organ. 1996;74:307-318.
7. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev. 1997;55:31-43.
8. Sauvaget C, Nagano J, Allen N, Grant EJ, Beral V. Intake of animal products and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Int J Epidemiol. 2003;32:536-543.
9. Jemal A, Bray F, Center MM, etal. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
10. Ziegler RG, Hoover RN, Pike MC, etal. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993;85:1819-1827.
11. Verschuren WM, Jacobs DR, Bloemberg BP, etal. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study. JAMA. 1995;274:131-136.
12. Menotti A, Lanti M, Kromhout D, etal. Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries Study. Eur J Cardiovasc Prev Rehabil. 2008;15:719-725.
13. Rumana N, Kita Y, Turin TC, etal. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry, 1990-2001. Am J Epidemiol. 2008;167:1358-1364.
14. Iso H, Date C, Noda H, etal. Frequency of food intake and estimated nutrient intake among men and women: the JACC Study. J Epidemiol. 2005;15(Suppl 1):S24-S42.
15. Nagataki S. The average of dietary iodine intake due to the ingestion of seaweeds is 1.2 mg/day in Japan. Thyroid. 2008;18:667-668.
16. Liu L, Heinrich M, Myers S, etal. Towards a better understanding of medicinal uses of the brown seaweed Sargassum in Traditional Chinese Medicine: a phytochemical and pharmacological review. J Ethnopharmacol. 2012;142:591-619.
17. Yamori Y, Liu L, Mizushima S, etal. Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens. 2006;24:1499-1505.
18. Iso H, Kubota Y. Nutrition and disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev. 2007;8(Suppl):35-80.
19. Shimazu T, Kuriyama S, Hozawa A, etal. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol. 2007;36:600-609.
20. Yamori Y, Miura A, Taira K. Implications from and for food cultures for cardiovascular diseases: Japanese food, particularly Okinawan diets. Asia Pac J Clin Nutr. 2001;10:144-145.
21. Cumashi A, Ushakova NA, Preobrazhenskaya ME, etal. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007;17:541-552.
22. Bocanegra A, Bastida S, Benedi J, etal. Characteristics and nutritional and cardiovascular-health properties of seaweeds. J Med Food. 2009;12:236-258.
23. Ikeda K, Kitamura A, Machida H, etal. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2003;30:44-48.
24. Matanjun P, Mohamed S, Muhammad K, etal. Comparison of cardiovascular protective effects of tropical seaweeds, Kappaphycus alvarezii, Caulerpa lentillifera, and Sargassum polycystum, on high-cholesterol/high-fat diet in rats. J Med Food. 2010;13:792-800.
25. Berteau O, Mulloy B. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology. 2003;13:29R-40R.
26. Heo SJ, Park EJ, Lee KW, etal. Antioxidant activities of enzymatic extracts from brown seaweeds. Bioresour Technol. 2005;96:1613-1623.
27. Ostergaard C, Yieng-Kow RV, Benfield T, etal. Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun. 2000;68:3153-3157.
28. Miao HQ, Elkin M, Aingorn E, etal. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer. 1999;83:424-431.
29. Cheong SH, Kim MY, Sok DE, etal. Spirulina prevents atherosclerosis by reducing hypercholesterolemia in rabbits fed a high-cholesterol diet. J Nutr Sci Vitaminol (Tokyo). 2010;56:34-40.
30. Nagaoka S, Shimizu K, Kaneko H, etal. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J Nutr. 2005;135:2425-2430.
31. Riss J, Decorde K, Sutra T, etal. Phycobiliprotein C-phycocyanin from Spirulina platensis is powerfully responsible for reducing oxidative stress and NADPH oxidase expression induced by an atherogenic diet in hamsters. J Agric Food Chem. 2007;55:7962-7967.
32. Khan M, Varadharaj S, Shobha JC, etal. C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes. J Cardiovasc Pharmacol. 2006;47:9-20.
33. Ionov VA, Basova MM. Use of blue-green micro-seaweed Spirulina platensis for the correction of lipid and hemostatic disturbances in patients with ischemic heart disease [in Russian]. Vopr Pitan. 2003;72:28-31.
34. Kurashige M, Okimasu E, Inoue M, etal. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR. 1990;22:27-38.
35. Park JS, Chyun JH, Kim YK, etal. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond). 2010;7:18. doi: 10.1186/1743-7075-7-18.
36. Cohen MC, McKenna C, Lewis SM, etal. Requirements for controlled clinical trials of preoperative cardiovascular risk reduction. Control Clin Trials. 1995;16:89-95.
37. Manerba A, Vizzardi E, Metra M, etal. n-3 PUFAs and cardiovascular disease prevention. Future Cardiol. 2010;6:343-350.
38. Gerber PA, Gouni-Berthold I, Berneis K. Omega-3 fatty acids: role in metabolism and cardiovascular disease. Curr Pharm Des. 2013;19:3074-3093.
39. Lopez-Rubio A, Gavara R, Lagaron JM. Bioactive packaging: turning foods into healthier foods through biomaterials. Trends Food Sci Technol. 2006;17:567-575.
40. Baucells MD, Crespo N, Barroeta AC, etal. Incorporation of different polyunsaturated fatty acids into eggs. Poult Sci. 2000;79:51-59.
41. Conquer JA, Holub BJ. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr. 1996;126:3032-3039.
42. Neff LM, Culiner J, Cunningham-Rundles S, etal. Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. J Nutr. 2011;141:207-213.
43. Geppert J, Kraft V, Demmelmair H, etal. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial. Br J Nutr. 2006;95:779-786.
44. Geppert J, Kraft V, Demmelmair H, etal. Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids. 2005;40:807-814.
45. Ichimura M, Kato S, Tsuneyama K, Matsutake S, Kamogawa M, Hirao E, Miyata A, Mori S, Yamaguchi N, Suruga K, Omagari K. Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome. Nutr Res. 2013 May;33(5):397-405.
46. Yeh CJ, Chang HY, Pan WH. Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008. Asia Pac J Clin Nutr. 2011;20:292-300.
47. Teas J, Baldeon ME, Chiriboga DE, etal. Could dietary seaweed reverse the metabolic syndrome? Asia Pac J Clin Nutr. 2009;18:145-154.
48. Shin A, Lim SY, Sung J, etal. Dietary intake, eating habits, and metabolic syndrome in Korean men. J Am Diet Assoc. 2009;109:633-640.
49. Selassie M, Sinha AC. The epidemiology and aetiology of obesity: a global challenge. Best Pract Res Clin Anaesthesiol. 2011;25:1-9.
50. Haslam D. What's new - tackling childhood obesity. Practitioner. 2006;250:26-27, 29, 31-22 passim.
51. Kristensen M, Jensen MG. Dietary fibres in the regulation of appetite and food intake. Importance of viscosity. Appetite. 2011;56:65-70.
52. MacArtain P, Gill CI, Brooks M, etal. Nutritional value of edible seaweeds. Nutr Rev. 2007;65(12 Pt 1):535-543.
53. Hall AC, Fairclough AC, Mahadevan K, etal. Ascophyllum nodosum enriched bread reduces subsequent energy intake with no effect on post-prandial glucose and cholesterol in healthy, overweight males. A pilot study. Appetite. 2012;58:379-386.
54. An C, Kuda T, Yazaki T, etal. FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas. Appl Environ Microbiol. 2013;79:860-866.
55. 13C]acetate into plasma lipids in humans. Am J Clin Nutr. 1995;61:1241-1247.
56. Paxman J. Daily ingestion of alginate reduces energy intake in free-living subjects. Appetite. 2008;51:713-719.
57. Paxman JR, Richardson JC, Dettmar PW, etal. Alginate reduces the increased uptake of cholesterol and glucose in overweight male subjects: a pilot study. Nutr Res. 2008;28:501-505.
58. Williams JA, Lai CS, Corwin H, etal. Inclusion of guar gum and alginate into a crispy bar improves postprandial glycemia in humans. J Nutr. 2004;134:886-889.
59. Wolf BW, Lai CS, Kipnes MS, etal. Glycemic and insulinemic responses of nondiabetic healthy adult subjects to an experimental acid-induced viscosity complex incorporated into a glucose beverage. Nutrition. 2002;18:621-626.
60. Pelkman CL, Navia JL, Miller AE, etal. Novel calcium-gelled, alginate-pectin beverage reduced energy intake in nondieting overweight and obese women: interactions with dietary restraint status. Am J Clin Nutr. 2007;86:1595-1602.
61. Georg Jensen M, Kristensen M, Belza A, etal. Acute effect of alginate-based preload on satiety feelings, energy intake, and gastric emptying rate in healthy subjects. Obesity (Silver Spring). 2012;20:1851-1858.
62. Georg Jensen M, Kristensen M, Astrup A. Can alginate-based preloads increase weight loss beyond calorie restriction? A pilot study in obese individuals. Appetite. 2011;57:601-604.
63. Georg Jensen M, Kristensen M, Astrup A. Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial. Am J Clin Nutr. 2012;96:5-13.
64. Odunsi ST, Vazquez-Roque MI, Camilleri M, etal. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring). 2010;18:1579-1584.
65. Maeda H, Tsukui T, Sashima T, etal. Seaweed carotenoid, fucoxanthin, as a multi-functional nutrient. Asia Pac J Clin Nutr. 2008;17(Suppl 1):196-199.
66. Roberts AW. Cardiovascular risk and prevention in diabetes mellitus. Clin Med. 2010;10:495-499.
67. Murata M, Ishihara K, Saito H. Hepatic fatty acid oxidation enzyme activities are stimulated in rats fed the brown seaweed, Undaria pinnatifida (wakame). J Nutr. 1999;129:146-151.
68. Maeda H, Hosokawa M, Sashima T, etal. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol Med Rep. 2009;2:897-902.
69. Lee HY, Won JC, Kang YJ, etal. Type 2 diabetes in urban and rural districts in Korea: factors associated with prevalence difference. J Korean Med Sci. 2010;25:1777-1783.
70. Paradis ME, Couture P, Lamarche B. A randomised crossover placebo-controlled trial investigating the effect of brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) on postchallenge plasma glucose and insulin levels in men and women. Appl Physiol Nutr Metab. 2011;36:913-919.
71. Torsdottir I, Alpsten M, Holm G, etal. A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes. J Nutr. 1991;121:795-799.
72. Maeda H, Yamamoto R, Hirao K, etal. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes Obes Metab. 2005;7:40-46.
73. Kim MS, Kim JY, Choi WH, etal. Effects of seaweed supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Nutr Res Pract. 2008;2:62-67.
74. Tuohy KM, Probert HM, Smejkal CW, etal. Using probiotics and prebiotics to improve gut health. Drug Discov Today. 2003;8:692-700.
75. Rowland I. Optimal nutrition: fibre and phytochemicals. Proc Nutr Soc. 1999;58:415-419.
76. Rastall RA, Gibson GR, Gill HS, etal. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol. 2005;52:145-152.
77. Blaut M, Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr. 2007;137(Suppl):S751-S755.
78. Cani PD, Neyrinck AM, Fava F, etal. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-2383.
79. Vaugelade P, Hoebler C, Bernard F, etal. Non-starch polysaccharides extracted from seaweed can modulate intestinal absorption of glucose and insulin response in the pig. Reprod Nutr Dev. 2000;40:33-47.
80. Devillé C, Damas J, Forget P, etal. Laminarin in the dietary fibre concept. J Sci Food Agric. 2004;84:1030-1038.
81. Devillé C, Gharbi M, Dandrifosse G, etal. Study on the effects of laminarin, a polysaccharide from seaweed, on gut characteristics. J Sci Food Agric. 2007;87:1717-1725.
82. Ramnani P, Chitarrari R, Tuohy K, etal. In vitro fermentation and prebiotic potential of novel low molecular weight polysaccharides derived from agar and alginate seaweeds. Anaerobe. 2012;18:1-6.
83. O'Sullivan L, Murphy B, McLoughlin P, etal. Prebiotics from marine macroalgae for human and animal health applications. Mar Drugs. 2010;8:2038-2064.
84. Ding WK, Shah NP. Effect of various encapsulating materials on the stability of probiotic bacteria. J Food Sci. 2009;74:M100-M107.
85. Islam MA, Yun CH, Choi YJ, etal. Microencapsulation of live probiotic bacteria. J Microbiol Biotechnol. 2010;20:1367-1377.
86. Chavarri M, Maranon I, Ares R, etal. Microencapsulation of a probiotic and prebiotic in alginate-chitosan capsules improves survival in simulated gastro-intestinal conditions. Int J Food Microbiol. 2010;142:185-189.
87. Harvey N, Dennison E, Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol. 2010;6:99-105.
88. Bonjour JP, Gueguen L, Palacios C, etal. Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr. 2009;101:1581-1596.
89. Tang BM, Eslick GD, Nowson C, etal. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370:657-666.
90. Cashman KD. Calcium and vitamin D. Novartis Found Symp. 2007;282:123-138; discussion 138-142, 212-218.
91. Scholz-Ahrens KE, Ade P, Marten B, etal. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr. 2007;137(Suppl):S838-S846.
92. Shin CS, Choi HJ, Kim MJ, etal. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone. 2010;47:378-387.
93. Shaw CK. An epidemiologic study of osteoporosis in Taiwan. Ann Epidemiol. 1993;3:264-271.
94. Fujita T, Ohue T, Fujii Y, etal. Heated oyster shell-seaweed calcium (AAA Ca) on osteoporosis. Calcif Tissue Int. 1996;58:226-230.
95. Fujita T. Osteoporosis: past, present and future. Osteoporos Int. 1997;7(Suppl 3):S6-S9.
96. Fujita T, Fujii Y, Goto B, etal. Peripheral computed tomography (pQCT) detected short-term effect of AAACa (heated oyster shell with heated algal ingredient HAI): a double-blind comparison with CaCO3 and placebo. J Bone Miner Metab. 2000;18:212-215.
97. Frestedt JL, Walsh M, Kuskowski MA, etal. A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J. 2008;7:9. doi: 10.1186/1475-2891-7-9.
98. Frestedt JL, Kuskowski MA, Zenk JL. A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: a randomised, placebo controlled pilot study. Nutr J. 2009;8:7.
99. Myers SP, O'Connor J, Fitton JH, etal. A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis. Biologics. 2010;4:33-44.
100. Hartman AA. Hyperthyroidism during administration of kelp tablets [in Dutch]. Ned Tijdschr Geneeskd. 1990;134:1373.
101. de Smet PA, Stricker BH, Wilderink F, etal. Hyperthyroidism during treatment with kelp tablets [in Dutch]. Ned Tijdschr Geneeskd. 1990;134:1058-1059.
102. Eliason BC. Transient hyperthyroidism in a patient taking dietary supplements containing kelp. J Am Board Fam Pract. 1998;11:478-480.
103. Henzen C, Buess M, Brander L. Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture [in German]. Schweiz Med Wochenschr. 1999;129:658-664.
104. Mussig K, Thamer C, Bares R, etal. Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea. J Gen Intern Med. 2006;21:C11-C14.
105. Teas J, Braverman LE, Kurzer MS, etal. Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food. 2007;10:90-100.
106. Konno N, Makita H, Yuri K, etal. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab. 1994;78:393-397.
107. Teas J. The consumption of seaweed as a protective factor in the etiology of breast cancer. Med Hypotheses. 1981;7:601-613.
108. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-781.
109. Parkin DM, Bray F, Ferlay J, etal. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
110. Yang YJ, Nam SJ, Kong G, etal. A case-control study on seaweed consumption and the risk of breast cancer. Br J Nutr. 2010;103:1345-1353.
111. Key TJ, Sharp GB, Appleby PN, etal. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 1999;81:1248-1256.
112. Kwon MJ, Nam TJ. Porphyran induces apoptosis related signal pathway in AGS gastric cancer cell lines. Life Sci. 2006;79:1956-1962.
113. Hwang HJ, Kwon MJ, Kim IH, etal. Chemoprotective effects of a protein from the red algae Porphyra yezoensis on acetaminophen-induced liver injury in rats. Phytother Res. 2008;22:1149-1153.
114. Okai Y, Higashi-Okai K, Yano Y, etal. Identification of antimutagenic substances in an extract of edible red alga, Porphyra tenera (Asakusa-nori). Cancer Lett. 1996;100:235-240.
115. Cann SA, van Netten JP, van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control. 2000;11:121-127.
116. Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia. 2005;10:189-196.
117. Miller D. Iodine. High-dose intake cuts breast cancer and hypothyroid-related illness. Caduceus. 2008;75:18-21.
118. Lee SM, Lewis J, Buss DH, etal. Iodine in British foods and diets. Br J Nutr. 1994;72:435-446.
119. Serra Majem LL, Tresserras R, Canela J, etal. Dietary iodine deficiency and breast cancer mortality: an ecological study. Int J Epidemiol. 1988;17:686-687.
120. Ghent WR, Eskin BA, Low DA, etal. Iodine replacement in fibrocystic disease of the breast. Can J Surg. 1993;36:453-460.
121. Tokudome S, Kuriki K, Moore MA. Seaweed and cancer prevention. Jpn J Cancer Res. 2001;92:1008-1009.
122. Michikawa T, Inoue M, Shimazu T, etal. Seaweed consumption and the risk of thyroid cancer in women: the Japan Public Health Center-based Prospective Study. Eur J Cancer Prev. 2012;21:254-260.
123. Teas J, Hurley TG, Hebert JR, etal. Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women. J Nutr. 2009;139:939-944.
124. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol. 2007;106:24-30.
125. Fishman J, Schneider J, Hershcope RJ, etal. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem. 1984;20(4B):1077-1081.
126. Kabat GC, Chang CJ, Sparano JA, etal. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 1997;6:505-509.
127. Muti P, Bradlow HL, Micheli A, etal. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology. 2000;11:635-640.
128. Skibola CF. The effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: a case report. BMC Complement Altern Med. 2004;4:10. doi: 10.1186/1472-6882-4-10.
129. Allen NE, Sauvaget C, Roddam AW, etal. A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control. 2004;15:911-920.
130. Severson RK, Nomura AM, Grove JS, etal. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989;49:1857-1860.
131. Hoshiyama Y, Sasaba T. A case-control study of single and multiple stomach cancers in Saitama Prefecture, Japan. Jpn J Cancer Res. 1992;83:937-943.
132. Chyou PH, Nomura AM, Stemmermann GN. Diet, alcohol, smoking and cancer of the upper aerodigestive tract: a prospective study among Hawaii Japanese men. Int J Cancer. 1995;60:616-621.
133. Mathew B, Sankaranarayanan R, Nair PP, etal. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer. 1995;24:197-202.
134. Scheuer PF, Hamann MT, Gravolos DG, inventors; Pharma Mar, s.a., assignee. Cytotoxic and antiviral compound. US patent 6011010. Jan 4, 2000.
135. Suarez Y, Gonzalez L, Cuadrado A, etal. Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells. Mol Cancer Ther. 2003;2:863-872.
136. Teas J, Hebert JR, Fitton JH, etal. Algae - a poor man's HAART? Med Hypotheses. 2004;62:507-510.
137. Soeda S, Ishida S, Shimeno H, etal. Inhibitory effect of oversulfated fucoidan on invasion through reconstituted basement-membrane by murine Lewis lung-carcinoma. Jpn J Cancer Res. 1994;85:1144-1150.
138. Aisa Y, Miyakawa Y, Nakazato T, etal. Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol. 2005;78:7-14.
139. Trinchero J, Ponce NM, Cordoba OL, etal. Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis. Phytother Res. 2009;23:707-712.
140. Grassauer A, Weinmuellner R, Meier C, etal. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol J. 2008;5:107. doi: 10.1186/1743-422X-5-107.
141. Zeitlin L, Whaley KJ. Microbicides for preventing transmission of genital herpes. Herpes. 2002;9:4-9.
142. Spieler R. Seaweed compound's anti-HIV efficacy will be tested in southern Africa. Lancet. 2002;359:1675.
143. Skoler-Karpoff S, Ramjee G, Ahmed K, etal. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1977-1987.
144. Teas J, Irhimeh MR. Dietary algae and HIV/AIDS: proof of concept clinical data. J Appl Phycol. 2012;24:575-582.
145. Cooper R, Dragar C, Elliot K, etal. GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes. BMC Complement Altern Med. 2002;2:11. doi: 10.1186/1472-6882-2-11.
146. Wang H, Ooi EV, Ang PO Jr. Antiviral activities of extracts from Hong Kong seaweeds. J Zhejiang Univ Sci B. 2008;9:969-976.